Advertisement
Advertisement
U.S. Markets open in 1 hr 44 mins
Advertisement
Advertisement
Advertisement
Advertisement

ZIVO Bioscience, Inc. (ZIVO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.0100+0.2100 (+7.50%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.8000
Open2.7750
Bid2.7800 x 800
Ask3.9100 x 1400
Day's Range2.7750 - 3.0300
52 Week Range2.3700 - 4.6000
Volume10,378
Avg. Volume11,540
Market Cap28.353M
Beta (5Y Monthly)0.00
PE Ratio (TTM)N/A
EPS (TTM)-0.0220
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    ZIVO Bioscience CEO Issues Letter to Shareholders

    BLOOMFIELD HILLS, Mich., September 23, 2022--Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today issued the following letter to shareholders from its Chairman, President and Chief Executive Officer, John Payne.

  • Business Wire

    ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment

    BLOOMFIELD HILLS, Mich., August 10, 2022--ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the "Company"), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces receipt of a letter from the U.S. Department of Agriculture’s (USDA) Center for Veterinary Biologics (CVB) affirming that the agency has claimed jurisdiction for reviewing the Company’s novel immune-modulating biologic for treating cocc

  • Business Wire

    Zivo Bioscience Joins Russell Microcap® Index

    BLOOMFIELD HILLS, Mich., June 27, 2022--ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the "Company"), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced that, effective today, June 27, 2022, it has joined the Russell Microcap® Index (^RUMIC) as a result of the 2022 Russell indexes annual reconstitution.

Advertisement
Advertisement